Implication of JAK1, JAK2, and JAK3 in the Realization of Proliferation and Differentiation Potential of Mesenchymal Progenitor Cells In Vitro


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Только для подписчиков

Аннотация

Involvement of individual JAK kinases in the realization of growth potential of mesenchymal progenitor cells was examined in vitro. Important role of JAK2 and JAK3 in determining the initial level of mitotic activity of progenitor cells was established. The yield of fibroblast CFUF was suppressed under the effect of specific inhibitors of JAK kinases. Blockade of JAK3 increased the rate of progenitor element differentiation. JAK1 had no effect on proliferation and differentiation status of progenitor cells.

Об авторах

G. Zyuz’kov

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine; National Research Tomsk State University

Автор, ответственный за переписку.
Email: zgn@pharm.tsu.ru
Россия, Tomsk; Tomsk

V. Zhdanov

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Россия, Tomsk

E. Udut

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Россия, Tomsk

L. Miroshnichenko

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Россия, Tomsk

E. Simanina

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Россия, Tomsk

T. Polyakova

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Россия, Tomsk

A. Chaikovskii

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Россия, Tomsk

L. Stavrova

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Россия, Tomsk

V. Udut

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine; National Research Tomsk State University

Email: zgn@pharm.tsu.ru
Россия, Tomsk; Tomsk

V. Agafonov

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Россия, Tomsk

Ya. Burmina

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Россия, Tomsk

M. Danilets

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Россия, Tomsk

M. Minakova

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Россия, Tomsk

A. Dygai

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Россия, Tomsk


© Springer Science+Business Media New York, 2016

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах